Abstracts and ePosters are open access. Presentations and webcasts from MAP Virtual Congress 2020 are restricted to ESMO members and delegates according to the presenters' agreement to release them.
Molecular Analysis for Precision Oncology Virtual Congress 2020
- Start date
- 09 Oct 2020
- End date
- 10 Oct 2020
As a leading congress in precision medicine in oncology, MAP was established by key opinion leaders in the field. MAP 2020 offered the same top-tier scientific research and education, and industry engagement that congress attendees are accustomed to, in an all-new digital environment.
Founded by Jean-Charles Soria, Fabrice André and Charles Swanton, the MAP Congress has established itself as a point of reference for all specialists wishing to create a bright future for precision medicine in oncology, by delivering a highly specific, minimally toxic and dramatically effective treatment for each patient.
The name of the Congress was recently changed into Molecular Analysis for Precision Oncology to better reflect its aim of focusing on science, translational research, education and collaboration.
Attendees of the MAP 2020 Virtual Congress, learned how to integrate insights from tumour sample analysis into daily practice, how to seek and identify actionable mutations in patient DNA and how to provide the best possible personalised treatment.
The MAP Congress is the result of a close partnership among Cancer Research UK (CRUK), the European Society for Medical Oncology (ESMO) and Unicancer, all committed to offering the best care to people with cancer worldwide, through oncology education and research.
The MAP 2020 Virtual Congress programme is now online!
Find out who are the MAP Virtual 2020 Congress Officers
Information for Presenters
Find here instructions to assist with your presentation
Industry partners: find out how to get involved
The abstract submission system is closed.
Press & Media
Information for media representatives
Get in touch with the organisers of MAP Virtual 2020. You'll find the contact details here